Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
Chuanjie Wu(Capital Medical University), Lijun Wang(Peking University), Haifeng Zhang(Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine), Yuan Chen, Nanchang Xie(First Affiliated Hospital of Zhengzhou University), Yajun Lian(First Affiliated Hospital of Zhengzhou University), Yake Zheng(First Affiliated Hospital of Zhengzhou University)
Cited by 217
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
|Stroke|2017|174
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
|The Journal of Headache and Pain|2014|170
Safety, feasibility, and potential efficacy of intraarterial selective cooling infusion for stroke patients treated with mechanical thrombectomy
|Journal of Cerebral Blood Flow & Metabolism|2018|118
Large Language Models in Medicine: Applications, Challenges, and Future Directions
|International Journal of Medical Sciences|2025|118